Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors

Behavioural Brain Research

Volumn 250, Issue , 2013, Pages 23-27

  Do Monte, Fabricio H ^a   Souza, Rimenez R ^a   Bitencourt, Rafael M ^a   Kroon, Juliana A ^a   Takahashi, Reinaldo N ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Cannabidiol; CB1 receptor; Conditioned freezing; Fear extinction; Infralimbic cortex; Rimonabant

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; FEAR EXTINCTION; FREEZING; INFRALIMBIC CORTEX; LIMBIC CORTEX; MALE; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STIMULUS RESPONSE;

ANIMALS; CANNABIDIOL; CANNABINOID RECEPTOR ANTAGONISTS; CEREBRAL CORTEX; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROSHOCK; EXTINCTION, PSYCHOLOGICAL; FEAR; FREEZING REACTION, CATALEPTIC; MALE; MICROINJECTIONS; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; TIME FACTORS;

EID: 84878163081     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.04.045     Document Type: Article

References (39)

1. Mechoulam R., Peters M., Murillo-Rodriguez E., Hanus L.O. Cannabidiol - recent advances. Chemical Biodiversity 2007, 4:1678-1692.
2. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce. Nature Reviews Drug Discovery 2008, 7:438-455.
3. Izzo A.A., Borrelli F., Capasso R., Di Marzo V., Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences 2009, 30:515-527.
4. Bisogno T., Hanus L., De Petrocellis L., Tchilibon S., Ponde D.E., Brandi I., et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. British Journal of Pharmacology 2001, 134:845-852.
5. Riebe C.J., Pamplona F.A., Kamprath K., Wotjak C.T. Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it. Neuroscience 2012, 204:159-185.
6. Chhatwal J.P., Davis M., Maguschak K.A., Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 2005, 30:516-524.
7. Lin H.C., Mao S.C., Su C.L., Gean P.W. The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cerebral Cortex 2009, 19:165-175.
8. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
9. de Oliveira Alvares L., Pasqualini Genro B., Diehl F., Molina V.A., Quillfeldt J.A. Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 2008, 154:1648-1655.
10. Bitencourt R.M., Pamplona F.A., Takahashi R.N. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. European Neuropsychopharmacology 2008, 18:849-859.
11. McDonald A.J., Mascagni F. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 2001, 107:641-652.
12. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
13. Wedzony K., Chocyk A. Cannabinoid CB1 receptors in rat medial prefrontal cortex are colocalized with calbindin- but not parvalbumin- and calretinin-positive GABA-ergic neurons. Pharmacological Reports 2009, 61:1000-1007.
14. Milad M.R., Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002, 420:70-74.
15. Laurent V., Westbrook R.F. Inactivation of the infralimbic but not the prelimbic cortex impairs consolidation and retrieval of fear extinction. Learning & Memory 2009, 16:520-529.
16. Do-Monte F.H., Allensworth M., Carobrez A.P. Impairment of contextual conditioned fear extinction after microinjection of alpha-1-adrenergic blocker prazosin into the medial prefrontal cortex. Behavioural Brain Research 2010, 211:89-95.
17. Guide for the care and use of laboratory animals 2011, Institute for Laboratory Animal Research, National Academies Press, Washington, DC, (xxv, pp. 220). eighth ed.
18. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic, Sydney. third ed.
19. Pamplona F.A., Prediger R.D., Pandolfo P., Takahashi R.N. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berlin) 2006, 188:641-649.
20. Lemos J.I., Resstel L.B., Guimaraes F.S. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behavioural Brain Research 2010, 207:105-111.
21. Bustos S.G., Maldonado H., Molina V.A. Disruptive effect of midazolam on fear memory reconsolidation: decisive influence of reactivation time span and memory age. Neuropsychopharmacology 2009, 34:446-457.
22. Santos N.C., Figueira-Coelho J., Martins-Silva J., Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochemical Pharmacology 2003, 65:1035-1041.
23. Fraser G.A. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neuroscience & Therapeutics 2009, 15:84-88.
24. Rabinak C.A., Angstadt M., Sripada C.S., Abelson J.L., Liberzon I., Milad M.R., et al. Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology 2013, 64:396-402.
25. Sim-Selley L.J., Martin B.R. Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. Journal of Pharmacology and Experimental Therapeutics 2002, 303:36-44.
26. Pamplona F.A., Takahashi R.N. Psychopharmacology of the endocannabinoids: far beyond anandamide. Journal of Psychopharmacology 2012, 26:7-22.
27. Sylantyev S., Jensen T.P., Ross R.A., Rusakov D.A. Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proceedings of the National Academy of Sciences United States of America 2013, 110:5193-5198.
28. Sotres-Bayon F., Quirk G.J. Prefrontal control of fear: more than just extinction. Current Opinion in Neurobiology 2010, 20:231-235.
29. Sierra-Mercado D., Padilla-Coreano N., Quirk G.J. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011, 36:529-538.
30. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learning & Memory 2006, 13:728-733.
31. Quirk G.J., Likhtik E., Pelletier J.G., Pare D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. Journal of Neuroscience 2003, 23:8800-8807.
32. Likhtik E., Popa D., Apergis-Schoute J., Fidacaro G.A., Pare D. Amygdala intercalated neurons are required for expression of fear extinction. Nature 2008, 454:642-645.
33. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
34. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., et al. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. Journal of Neuroscience 2005, 25:6845-6856.
35. Foldy C., Neu A., Jones M.V., Soltesz I. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. Journal of Neuroscience 2006, 26:1465-1469.
36. Moreira F.A., Aguiar D.C., Guimaraes F.S. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30:1466-1471.
37. Stern C.A., Gazarini L., Takahashi R.N., Guimaraes F.S., Bertoglio L.J. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology 2012, 37:2132-2142.
38. Bergamaschi M.M., Queiroz R.H., Chagas M.H., de Oliveira D.C., De Martinis B.S., Kapczinski F., et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 2011, 36:1219-1226.
39. Das R.K., Kamboj S.K., Ramadas M., Yogan K., Gupta V., Redman E., et al. Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology 2013.